Gain Therapeutics GANX
NASDAQ GANX
$1.25 -0.03 (-2.70%)
As of: Oct 23, 2026 · 3:59 PM EDT

Gain Therapeutics (GANX) Cash & Current Investments (2020 - 2026)

Updated

Gain Therapeutics (GANX) reported Cash & Current Investments of $13.1 million for Q2 2026, up 95.5% from $6.7 million a year earlier but down 20.8% from the prior quarter.

Analysis

Gain Therapeutics (GANX) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Gain Therapeutics posted Cash & Current Investments of $20.84 million, up 100.6% from FY2024.

  • Cash & Current Investments has a five-year compound annual growth rate of 22.7% (FY2020 to FY2025).
  • By year, Cash & Current Investments came in at $10.39 million in FY2024 (-38.2%), $16.79 million in FY2023 (-16.6%), $20.14 million in FY2022 (-45.4%) and $36.88 million in FY2021 (+392.2%).
  • Five-year quarterly Cash & Current Investments spans a low of $6.7 million in Q2 2025 and a high of $40.98 million in Q3 2021.
  • Year over year, Cash & Current Investments has now increased in each of the last three quarters, with growth averaging 15.3% over the last eight quarters.
  • The high point for year-over-year Cash & Current Investments in five years was Q4 2021 (growth of 392.2%); the low point was Q2 2025 (a decline of 60.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $16.54 million (Q1 2026), $20.84 million (Q4 2025) and $8.81 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Gain Therapeutics 54.24 Mn -5.04 Mn - 13.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.10 Mn
Mar 31, 2026 16.54 Mn
Dec 31, 2025 20.84 Mn
Sep 30, 2025 8.81 Mn
Jun 30, 2025 6.70 Mn
Mar 31, 2025 9.10 Mn
Dec 31, 2024 10.39 Mn
Sep 30, 2024 12.05 Mn
Jun 30, 2024 16.94 Mn
Mar 31, 2024 12.66 Mn
Dec 31, 2023 16.79 Mn
Sep 30, 2023 12.23 Mn
Jun 30, 2023 16.19 Mn
Mar 31, 2023 17.82 Mn
Dec 31, 2022 20.14 Mn
Sep 30, 2022 22.73 Mn
Jun 30, 2022 24.25 Mn
Mar 31, 2022 34.34 Mn
Dec 31, 2021 36.88 Mn
Sep 30, 2021 40.98 Mn
API Access

Gain Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=GANX&period=max&api_key=YOUR_API_KEY